BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9206686)

  • 21. Hepatitis-B vaccination.
    Phadke A; Kale A
    J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
    [No Abstract]   [Full Text] [Related]  

  • 22. Why should Australia adopt universal infant hepatitis B vaccination?
    Thompson SC; Oman K
    Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
    [No Abstract]   [Full Text] [Related]  

  • 23. Desirability and feasibility of hepatitis B vaccine in EPI.
    Mittal SK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors associated with hepatitis B virus immunization coverage at the beginning of a population campaign in the Lazio region, Italy.
    Faustini A; Spadea T; Fano V; Giorgi Rossi P; Sangalli M; Franco E; Perucci CA
    Prev Med; 2001 Nov; 33(5):409-14. PubMed ID: 11676581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protection of children born to hepatitis-B-infected mothers].
    Boot HJ; Vermeer-de Bondt PE; Kimman TG
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1816-8. PubMed ID: 15495509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should universal hepatitis B immunisation be introduced in the UK?
    English P
    Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B immunization schedule recommended by IAP.
    Paul Y
    Indian Pediatr; 2002 May; 39(5):503-4; author reply 504-5. PubMed ID: 12037289
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia.
    Levin CE; Nelson CM; Widjaya A; Moniaga V; Anwar C
    Bull World Health Organ; 2005 Jun; 83(6):456-61. PubMed ID: 15976897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
    Puliyel JM
    Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis B vaccination in France: vaccination coverage in 2002].
    Denis F
    Bull Acad Natl Med; 2004; 188(1):115-23. PubMed ID: 15368931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
    Zurn P; Danthine JP
    Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
    Chauvin P; Ekra D; Plotkin SA
    Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
    [No Abstract]   [Full Text] [Related]  

  • 34. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?
    Ganiats TG; Bowersox MT; Ralph LP
    J Fam Pract; 1993 Feb; 36(2):147-9. PubMed ID: 8426132
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.
    Jain N; Hennessey K
    J Adolesc Health; 2009 Jun; 44(6):561-7. PubMed ID: 19465320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Consider whooping cough also in adults. Interview by Dr. rer. nat. Anita Schweiger].
    Thilemann P
    Fortschr Med; 1997 Aug; 115(24):31-2. PubMed ID: 9410817
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers].
    van der Ploeg CP; Kateman H; Vermeer-de Bondt PE; Verkerk PH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1820-4. PubMed ID: 15495511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and control of hepatitis B in China.
    Sun Z; Ming L; Zhu X; Lu J
    J Med Virol; 2002 Jul; 67(3):447-50. PubMed ID: 12116043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.